These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 15201739

  • 1. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup.
    Palou J, Piovesan LF, Huguet J, Salvador J, Vicente J, Villavicencio H.
    J Urol; 2004 Jul; 172(1):66-9. PubMed ID: 15201739
    [Abstract] [Full Text] [Related]

  • 2. Percutaneous management of renal pelvic urothelial tumors: long-term followup.
    Goel MC, Mahendra V, Roberts JG.
    J Urol; 2003 Mar; 169(3):925-9; discussion 929-30. PubMed ID: 12576814
    [Abstract] [Full Text] [Related]

  • 3. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis.
    Patel A, Soonawalla P, Shepherd SF, Dearnaley DP, Kellett MJ, Woodhouse CR.
    J Urol; 1996 Mar; 155(3):868-74. PubMed ID: 8583595
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 13-year experience with percutaneous management of upper tract transitional cell carcinoma.
    Clark PE, Streem SB, Geisinger MA.
    J Urol; 1999 Mar; 161(3):772-5; discussion 775-6. PubMed ID: 10022682
    [Abstract] [Full Text] [Related]

  • 7. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
    Chen GL, Bagley DH.
    J Urol; 2000 Oct; 164(4):1173-6. PubMed ID: 10992360
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
    Koda S, Mita K, Shigeta M, Usui T.
    Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma.
    Wu CF, Chang PL, Chen CS, Chuang CK, Weng HH, Pang ST.
    J Urol; 2006 Aug; 176(2):477-81. PubMed ID: 16813872
    [Abstract] [Full Text] [Related]

  • 11. Imperative indications for conservative management of upper tract transitional cell carcinoma.
    Krambeck AE, Thompson RH, Lohse CM, Patterson DE, Elliott DS, Blute ML.
    J Urol; 2007 Sep; 178(3 Pt 1):792-6; discussion 796-7. PubMed ID: 17632132
    [Abstract] [Full Text] [Related]

  • 12. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
    Rouprêt M, Hupertan V, Traxer O, Loison G, Chartier-Kastler E, Conort P, Bitker MO, Gattegno B, Richard F, Cussenot O.
    Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
    [Abstract] [Full Text] [Related]

  • 13. Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma.
    Walton TJ, Sherwood BT, Parkinson RJ, Obakponovwe O, Thomas SA, Taylor MC, England RC, Lemberger RJ.
    J Urol; 2009 Feb; 181(2):532-9. PubMed ID: 19084866
    [Abstract] [Full Text] [Related]

  • 14. Percutaneous management of grade II upper urinary tract transitional cell carcinoma: the long-term outcome.
    Jabbour ME, Desgrandchamps F, Cazin S, Teillac P, Le Duc A, Smith AD.
    J Urol; 2000 Apr; 163(4):1105-7; quiz 1295. PubMed ID: 10737475
    [Abstract] [Full Text] [Related]

  • 15. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
    Kassouf W, Swanson D, Kamat AM, Leibovici D, Siefker-Radtke A, Munsell MF, Grossman HB, Dinney CP.
    J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
    [Abstract] [Full Text] [Related]

  • 16. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
    Stein JP, Clark P, Miranda G, Cai J, Groshen S, Skinner DG.
    J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
    [Abstract] [Full Text] [Related]

  • 17. Management of superficial transitional cell carcinoma in the intramural ureter: what to do?
    Palou J, Salvador J, Millán F, Collado A, Algaba F, Vicente J.
    J Urol; 2000 Mar; 163(3):744-7. PubMed ID: 10687968
    [Abstract] [Full Text] [Related]

  • 18. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
    Chou EC, Lin AT, Chen KK, Chang LS.
    Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
    [Abstract] [Full Text] [Related]

  • 19. Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?
    Volkmer BG, Schnoeller T, Kuefer R, Gust K, Finter F, Hautmann RE.
    J Urol; 2009 Dec; 182(6):2632-7. PubMed ID: 19836794
    [Abstract] [Full Text] [Related]

  • 20. [Ureteroscopy in the follow-up protocol for upper urinary tract urothelial tumors treated endoscopically].
    Amón Sesmero JH, Estébanez Zarranz J, Conde Redondo C, Robles Samaniego A, Del Valle González N, Martínez-Sagarra Oceja JM.
    Arch Esp Urol; 2004 Apr; 57(3):303-10. PubMed ID: 15174509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.